Syndax Pharmaceuticals Inc Annual Nonoperating Income (Expense) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Syndax Pharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
  • Syndax Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $5.45M, a 4.65% increase year-over-year.
  • Syndax Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $24.2M, a 38.2% increase year-over-year.
  • Syndax Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2023 was $20.6M, a 751% increase from 2022.
  • Syndax Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was $2.42M.
  • Syndax Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was -$1.29M, a 25.4% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $20.6M +$18.2M +751% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $2.42M +$3.71M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 -$1.29M +$441K +25.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$1.74M -$3.23M -216% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $1.49M -$423K -22.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $1.92M +$763K +66.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 $1.15M +$1.86M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
2016 -$706K +$2.9M +80.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 -$3.61M -$5.11M -340% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $1.5M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.